Similar articles for PMID: 30375835

Year	Number of Results
1977	1
1982	1
1996	2
1997	3
1998	7
1999	4
2000	5
2001	8
2002	11
2003	9
2004	8
2005	5
2006	7
2007	4
2008	5
2009	5
2010	4
2011	3
2012	4
2013	4
2014	4
2015	4
2016	5
2017	6
2018	7
2019	17
2020	18
2021	12
2022	8

1

Affect, interpersonal behaviour and interpersonal perception during open-label, uncontrolled paroxetine treatment of people with social anxiety disorder: a pilot study.

Rappaport LM, Russell JJ, Hedeker H, Pinard G, Bleau P, Moskowitz DS. Rappaport LM, et al. J Psychiatry Neurosci. 2018 Nov 1;43(6):407-415. doi: 10.1503/jpn.170141. J Psychiatry Neurosci. 2018. PMID: 30375835 Free PMC article. Clinical Trial.

2

Emotional and interpersonal mechanisms in community SSRI treatment of social anxiety disorder.

Rappaport LM, Hunter MD, Russell JJ, Pinard G, Bleau P, Moskowitz DS. Rappaport LM, et al. J Psychiatry Neurosci. 2021 Jan 4;46(1):E56-E64. doi: 10.1503/jpn.190164. J Psychiatry Neurosci. 2021. PMID: 33026311 Free PMC article.

3

Pharmacotherapy for social anxiety disorder: Interpersonal predictors of outcome and the mediating role of the working alliance.

Cohen JN, Drabick DAG, Blanco C, Schneier FR, Liebowitz MR, Heimberg RG. Cohen JN, et al. J Anxiety Disord. 2017 Dec;52:79-87. doi: 10.1016/j.janxdis.2017.10.004. Epub 2017 Nov 6. J Anxiety Disord. 2017. PMID: 29102818 Free PMC article. Clinical Trial.

4

Do venlafaxine XR and paroxetine equally influence negative and positive affect?

Dichter GS, Tomarken AJ, Freid CM, Addington S, Shelton RC. Dichter GS, et al. J Affect Disord. 2005 Apr;85(3):333-9. doi: 10.1016/j.jad.2004.10.007. J Affect Disord. 2005. PMID: 15780704 Clinical Trial.

5

Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial.

Stein MB, Liebowitz MR, Lydiard RB, Pitts CD, Bushnell W, Gergel I. Stein MB, et al. JAMA. 1998 Aug 26;280(8):708-13. doi: 10.1001/jama.280.8.708. JAMA. 1998. PMID: 9728642 Clinical Trial.

6

Spotlight on paroxetine in psychiatric disorders in adults.

Wagstaff AJ, Cheer SM, Matheson AJ, Ormrod D, Goa KL. Wagstaff AJ, et al. CNS Drugs. 2002;16(6):425-34. doi: 10.2165/00023210-200216060-00006. CNS Drugs. 2002. PMID: 12027788 Review.

7

A double-blind placebo-controlled trial of paroxetine in the management of social phobia (social anxiety disorder) in South Africa.

Stein DJ, Berk M, Els C, Emsley RA, Gittelson L, Wilson D, Oakes R, Hunter B. Stein DJ, et al. S Afr Med J. 1999 Apr;89(4):402-6. S Afr Med J. 1999. PMID: 10341825 Clinical Trial.

8

The Effects of Tryptophan on Everyday Interpersonal Encounters and Social Cognitions in Individuals with a Family History of Depression.

Hogenelst K, Schoevers RA, Aan Het Rot M. Hogenelst K, et al. Int J Neuropsychopharmacol. 2015 Mar 2;18(8):pyv012. doi: 10.1093/ijnp/pyv012. Int J Neuropsychopharmacol. 2015. PMID: 25733537 Free PMC article.

9

Tiagabine for the treatment of generalized anxiety disorder: a randomized, open-label, clinical trial with paroxetine as a positive control.

Rosenthal M. Rosenthal M. J Clin Psychiatry. 2003 Oct;64(10):1245-9. doi: 10.4088/jcp.v64n1016. J Clin Psychiatry. 2003. PMID: 14658975 Clinical Trial.

10

Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review.

Bourin M. Bourin M. Hum Psychopharmacol. 2003 Apr;18(3):185-90. doi: 10.1002/hup.467. Hum Psychopharmacol. 2003. PMID: 12672169 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed